Chronomodulated administration of oxaliplatin plus capecitabine (XELOX) as first line chemotherapy in advanced colorectal cancer patients: phase II study.

Source:http://linkedlifedata.com/resource/pubmed/id/16944151

Download in:

View as

General Info

PMID
16944151